FDA Inspection
EyePoint Pharmaceuticals, Inc.EyePoint Pharmaceuticals, Inc. – FDA Inspection, Sep 1, 2021
Record Details
This FDA Inspection record concerns EyePoint Pharmaceuticals, Inc., with an inspection on September 1, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- September 1, 2021
- Product Type
- Drugs
View Company Profile
ID · bc7824a1-722e-4a03-8af8-91a2affaaa96
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1150669
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
5- 21 CFR 314.81(b)(1)(ii)Failure to meet specifications
- 21 CFR 211.42(c)(10)(v)Cleaning System
- 21 CFR 211.100(b)Procedure Deviations Recorded and Justified
- 21 CFR 211.63Equipment Design, Size and Location
- 21 CFR 211.192Investigations of discrepancies, failures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of EyePoint Pharmaceuticals, Inc.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| February 15, 2024 | Not classified | New England District Office | Drug Quality Assurance |
| August 28, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 19, 2018 | Not classified | New England District Office | |
| April 4, 2018 | OAI | New England District Office | New Drug Evaluation |
Other documents for EyePoint Pharmaceuticals, Inc.
- FDA Inspection 1230113 - 2024-02-15
- FDA Inspection 1102130 - 2019-08-28
- FDA Inspection 1067552 - 2018-09-19
- FDA Inspection 1046783 - 2018-04-04
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.